---

President, CEO, and a member of the board at Daré Bioscience

A lifelong advocate for women’s healthcare issues, Johnson founded Daré Bioscience in 2015 and has served as President, CEO and a member of the board of directors since its inception and following its business combination with Cerulean Pharma in July 2017.

“We need to continue to do a better job as an industry by including women in clinical studies and understanding how disease (and treatments) manifest differently in women versus men. Doing so will improve the standard of care for everyone.”